Why women's health is the future of healthcare | Loulia Kassem | TEDxLausanneWomen

Quick Overview

Loulia Kassem advocates for modernizing medical diagnostics for women by integrating biological data, particularly vaginal fluids, to create personalized health monitoring tools that surpass outdated methods like calendar tracking, aiming to improve outcomes for conditions such as endometriosis and premature birth.

Key Points: Historical medical advice for women, like bed rest for menstrual pain or prescribing Thalidomide to pregnant women, demonstrates systemic medical bias against female health. Hippocrates' ancient belief that the wandering uterus caused anxiety and other problems illustrates the long history of misinterpreting female biology. The speaker highlights the severe underfunding of women's health research, noting that only 3% of the health research budget is allocated to it, despite women being half the population. Venture capital funding shows similar bias, with only 2% going to all-women founding teams as of 2025, compared to 83% going to all-men teams. Modern technology, like period tracking apps, only uses calendar math, ignoring rich biochemical data available in vaginal fluids, which could predict issues like premature birth. The speaker proposes creating a future 'Museum of Outdated Medical Advice for Women' to contrast historical neglect with modern, personalized diagnostics using bodily fluids. The goal is to develop technology that analyzes hormones, immune markers, bacteria, and proteins in fluids to offer better, dignity-preserving health monitoring.

Context: Loulia Kassem delivers a TEDx talk at TEDx Lausanne Women, titled "The Hidden Power in Women's Biology and How to Harness It." She critiques the historical and ongoing systemic bias in medical research and diagnostics that has largely ignored female-specific biological data. Kassem uses examples ranging from ancient beliefs about the wandering uterus to the Thalidomide tragedy and current funding disparities to argue for an urgent need to modernize women's health technology using personalized biomarker analysis.